Please login to the form below

Not currently logged in

Government Accountability Office

This page shows the latest Government Accountability Office news and features for those working in and with pharma, biotech and healthcare.

Audit office says FDA 'is not meeting safety data obligations'

Audit office says FDA 'is not meeting safety data obligations'

Audit office says FDA 'is not meeting safety data obligations'. Criticised for not effectively tracking information about approved drugs. ... The Government Accountability Office (GAO) says in a new report that the regulator is meeting its objectives for

Latest news

  • PhRMA report shows increased R&D spend

    The trade group released the survey results the day after the Government Accountability Office (GAO) announced the results of a study showing that prescription drug spending in 2009 totalled around $250bn, ... of which $78bn - or about 31 per cent - was

  • FDA heparin crisis response criticised

    FDA heparin crisis response criticised. The Government Accountability Office has issued a report critical of the US FDA's management of the 2008 heparin contamination crisis. ... The Government Accountability Office (GAO) has issued a report that is

  • Most postmarketing trials on-track, FDA says

    In a study released late last year by the Government Accountability Office, the FDA was criticised for not keeping track of postmarketing commitments and failing to enforce the requirements sufficiently.

  • PhRMA names board nominees

    legislation. The trade group sent a letter to the Government Accountability Office nominating Pfizer chief medical officer Freda Lewis-Hall; Joshua J Ofman, Amgen's vice president of Global Coverage and ... Reimbursement, Global Government Affairs and

  • Calls for drug price investigation

    Leaders of two powerful Congressional committees in the US have asked the Government Accountability Office (GAO) to investigate prescription drug pricing trends and develop a proposal for an ongoing monitoring programme ... That deal promised to cut $8bn

More from news
Approximately 1 fully matching, plus 10 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....